C. Efe Et Al. , "Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome," HEPATOLOGY , vol.76, no.6, pp.1576-1586, 2022
Efe, C. Et Al. 2022. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. HEPATOLOGY , vol.76, no.6 , 1576-1586.
Efe, C., Kulkarni, A. V., Terziroli Beretta-Piccoli, B., Magro, B., Friedrich Staettermayer, A., Cengiz, M., ... Clayton-Chubb, D.(2022). Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. HEPATOLOGY , vol.76, no.6, 1576-1586.
Efe, Cumali Et Al. "Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome," HEPATOLOGY , vol.76, no.6, 1576-1586, 2022
Efe, Cumali Et Al. "Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome." HEPATOLOGY , vol.76, no.6, pp.1576-1586, 2022
Efe, C. Et Al. (2022) . "Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome." HEPATOLOGY , vol.76, no.6, pp.1576-1586.
@article{article, author={Cumali Efe Et Al. }, title={Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome}, journal={HEPATOLOGY}, year=2022, pages={1576-1586} }